Amrize Ltd (NYSE:AMRZ - Get Free Report) CFO Baris Oran purchased 3,000 shares of the business's stock in a transaction on Tuesday, August 11th. The shares were acquired at an average price of $47.38 per share, for a total transaction of $142,140.00. Following the completion of the acquisition, the chief financial officer directly owned 3,000 shares in the company, valued at approximately $142,140. This represents a ∞ increase in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this link.
Amrize Trading Up 0.6%
Shares of AMRZ stock traded up $0.28 during trading hours on Thursday, hitting $46.65. 1,261,074 shares of the company were exchanged, compared to its average volume of 3,206,131. The company has a 50 day simple moving average of $51.50 and a two-hundred day simple moving average of $54.58. The firm has a market cap of $25.80 billion, a P/E ratio of 21.50, a P/E/G ratio of 1.02 and a beta of 0.11. The company has a debt-to-equity ratio of 0.38, a quick ratio of 0.89 and a current ratio of 1.40. Amrize Ltd has a fifty-two week low of $46.03 and a fifty-two week high of $65.94.
Amrize (NYSE:AMRZ - Get Free Report) last released its earnings results on Thursday, August 6th. The company reported $0.88 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.92 by ($0.04). The company had revenue of $3.50 billion for the quarter. Amrize had a net margin of 9.89% and a return on equity of 10.17%. Equities analysts anticipate that Amrize Ltd will post 2.72 EPS for the current year.
Amrize Announces Dividend
The business also recently disclosed a dividend, which will be paid on Wednesday, August 26th. Stockholders of record on Wednesday, August 19th will be issued a dividend of $0.11 per share. The ex-dividend date is Tuesday, August 18th. Amrize's dividend payout ratio is currently 20.28%.
Wall Street Analyst Weigh In
A number of research analysts recently weighed in on the company. Sanford C. Bernstein reaffirmed an "outperform" rating on shares of Amrize in a research note on Monday, June 22nd. Oppenheimer decreased their price objective on Amrize from $68.00 to $65.00 and set an "outperform" rating for the company in a report on Tuesday, July 21st. Royal Bank Of Canada lowered Amrize from a "sector perform" rating to an "underperform" rating and lowered their target price for the stock from $60.00 to $48.00 in a research report on Monday. Weiss Ratings cut Amrize from a "hold (c-)" rating to a "sell (d+)" rating in a report on Friday, July 31st. Finally, Morgan Stanley set a $63.00 price target on shares of Amrize and gave the company an "overweight" rating in a research report on Monday, June 22nd. One investment analyst has rated the stock with a Strong Buy rating, nine have issued a Buy rating, five have given a Hold rating and two have given a Sell rating to the stock. According to MarketBeat.com, Amrize has an average rating of "Moderate Buy" and an average price target of $60.57.
Get Our Latest Analysis on AMRZ
Institutional Inflows and Outflows
Hedge funds have recently modified their holdings of the stock. MCF Advisors LLC bought a new stake in Amrize during the fourth quarter worth $27,000. Basepoint Wealth LLC purchased a new position in Amrize during the 4th quarter worth $33,000. Laurel Wealth Advisors LLC bought a new stake in shares of Amrize in the 4th quarter worth $34,000. US Bancorp DE bought a new stake in shares of Amrize in the 3rd quarter worth $38,000. Finally, Itau Unibanco Holding S.A. raised its holdings in shares of Amrize by 150.0% in the fourth quarter. Itau Unibanco Holding S.A. now owns 750 shares of the company's stock valued at $41,000 after purchasing an additional 450 shares during the last quarter.
About Amrize
(
Get Free Report)
Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.
Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Amrize, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Amrize wasn't on the list.
While Amrize currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.